PilotHealth
MS trial tests red blood cells to retrain immunity
The approach attaches specific proteins to patients’ own red blood cells before returning them to the body.
Written by AI1 source1 min
Loading…
Diagnostics, prosthetics, vaccines, genomics: the medicine that adds years to a life.
Medicine that wins years of life: AI-assisted screening examining millions of patients, next-generation vaccines, genomics moving from sequencing to treatment, prosthetics and implants restoring lost abilities. The section follows completed clinical trials, market authorisations, hospital roll-outs — the moment a technology stops being a paper and becomes care.
The numbers rule: cohorts, detection rates, avoided mortality, costs. We gladly cover the health systems deploying at scale — India, Brazil, Southeast Asia — because frugal technologies often prove themselves there before arriving anywhere else. Every article rests on the trial, authorisation or study behind it, and cites them.
The approach attaches specific proteins to patients’ own red blood cells before returning them to the body.
At Saint Luke's Hospital, 54 hospitalized adults were randomly assigned to weighted-blanket or usual-care periods.
The study examined 61 healthy women aged 17–25 using stool sequencing and brain spectroscopy.
Clinicians can review notes, lab results, medicines and specialist records in some patient-chart workflows.
In a small study, ventilated COVID-19 patients received Auxora while researchers sampled their lungs.
The pain and touch signals looked similar in most cortical layers, but their blood-flow responses sharply diverged.
University of Utah researchers tested the approach in mouse models and human liver organoids.
NUS Medicine researchers traced heart damage to the loss of STMP1, a 47-amino-acid mitochondrial protein.
CameraJet will open for presales at 10 a.m. on September 7 for ¥3,899, with a camera, water flosser and AI recognition system.
Edinburgh researchers tested β-catenin, a cancer-linked protein, under two different buildup mechanisms.
The method distinguishes activated and quiescent immune cells without labels or destroying the sample.
The four-day treatment used organoids grown from mouse tumors and patient samples.
The estimate covers the United States from 1949 through 2024 and comes from a retrospective analysis.
Vanderbilt’s team found the liver kept releasing glucose at a later meal when morning glucagon was elevated.
An updated review covered 38 randomized trials involving 25,816 adults without diabetes.
A Rutgers trial followed 93 healthy women, 43% of them postmenopausal.
The 12-month regimen paired estriol, a pregnancy-associated estrogen, with progesterone.
Researchers identified 36 rare, risk-raising genes across OCD and chronic tic disorders.